$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Synergistic hepatoprotective effects of CGplus on CCl4-induced acute injury

Journal of ethnopharmacology, v.249, 2020년, pp.112441 -   

Lee, Myong-Min (Liver and Immunology Research Center, Korean Medical College of Daejeon University) ,  Kim, Hyeong-Geug (Liver and Immunology Research Center, Korean Medical College of Daejeon University) ,  Lee, Jin-Seok (Liver and Immunology Research Center, Korean Medical College of Daejeon University) ,  Lee, Sung-Bae (Liver and Immunology Research Center, Korean Medical College of Daejeon University) ,  Cho, Jung-Hyo (Liver and Immunology Research Center, Korean Medical College of Daejeon University) ,  Lee, Dong-Soo (Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea) ,  Lee, Nam-Hun (Liver and Immunology Research Center, Korean Medical College of Daejeon University) ,  Lee, Hwa-Dong (National Institute for Korean Medicine) ,  Moon, Sung-Ok (National Institute for Korean Medicine Republic) ,  Son, Chang-Gue

Abstract AI-Helper 아이콘AI-Helper

Abstract Ethnopharmacological relevance Traditional Chinese/Korean medicine suggests “blood stasis (瘀血)”, “stagnation of vital energy (气滯)” and “dampness and Phlegm (湿痰)” as the main etiologies of liver disorders, and multiherbal formulas are genera...

주제어

참고문헌 (41)

  1. J. Ethnopharmacol. Ai 146 794 2013 10.1016/j.jep.2013.02.005 Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: in vitro and in vivo studies 

  2. Int. J. Hepatol. Ambade 853175 2012 Oxidative stress and inflammation: essential partners in alcoholic liver disease 

  3. J. Biol. Chem. Beers 195 133 1952 10.1016/S0021-9258(19)50881-X A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase 

  4. Z. Naturforschung C Boll 56 649 2001 10.1515/znc-2001-7-826 Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites 

  5. Rev. Bras. Farmacogn. Carmona 23 379 2013 10.1590/S0102-695X2013005000018 Herbal medicines: old and new concepts, truths and misunderstandings 

  6. World J. Gastroenterol. Chen 12 5175 2006 Involvement of P53 and Bax/Bad triggering apoptosis in thioacetamide-induced hepatic epithelial cells 

  7. World J. Gastroenterol. Cichoż-Lach 20 8082 2014 10.3748/wjg.v20.i25.8082 Oxidative stress as a crucial factor in liver diseases 

  8. J. Neurosci. Cregan 19 7860 1999 10.1523/JNEUROSCI.19-18-07860.1999 Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons 

  9. J. Biochem. Mol. Biol. El-Beshbishy 38 300 2005 The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective 

  10. Biochim. Biophys. Acta Evans 33 574 1959 10.1016/0006-3002(59)90157-X The ionization of cysteine 

  11. Arch. Med. Res. Favari 28 11 1997 Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats 

  12. Molecules Federico 22 E191 2017 10.3390/molecules22020191 Silymarin/silybin and chronic liver disease: a marriage of many years 

  13. J. Gastroenterol. Hepatol. Gao 27 Suppl. 2 89 2012 10.1111/j.1440-1746.2011.07003.x Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease 

  14. J. Ethnopharmacol. Han 173 217 2015 10.1016/j.jep.2015.07.021 Synergistic effects of Artemisia iwayomogi and Curcuma longa radix on high-fat diet-induced hyperlipidemia in a mouse model 

  15. Hepatology Huber 39 1732 2004 10.1002/hep.20247 DDB treatment of patients with chronic hepatitis 

  16. Oncotarget Ivanov 8 3895 2017 10.18632/oncotarget.13904 Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis 

  17. Clin. Gastroenterol. Hepatol. Kanwal 14 301 2016 10.1016/j.cgh.2015.08.010 Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans 

  18. Sci. Rep. Kim 5 14531 2015 10.1038/srep14531 Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines 

  19. Evid. Based Complement Altern. Med. Kim 4390636 2017 Artemisia iwayomogi plus Curcuma longa synergistically ameliorates nonalcoholic steatohepatitis in HepG2 cells 

  20. Evid. Based Complement Altern. Med. Kim 5093718 2016 A herbal formula, CGXII, exerts antihepatofibrotic effect in dimethylnitrosamine-induced SD rat model 

  21. Comp. Biochem. Physiol. B Kurata 106 477 1993 10.1016/0305-0491(93)90121-K Antioxidant systems and erythrocyte life-span in mammals 

  22. Phytomedicine Lee 41 24 2018 10.1016/j.phymed.2018.01.020 CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model 

  23. Oxid. Med. Cell Longev. Li 4234061 2016 Insights into the role and interdependence of oxidative stress and inflammation in liver diseases 

  24. Int. J. Mol. Sci. Li 16 26087 2015 10.3390/ijms161125942 The role of oxidative stress and antioxidants in liver diseases 

  25. Anal. Biochem. Mihara 86 271 1978 10.1016/0003-2697(78)90342-1 Determination of malonaldehyde precursor in tissues by thiobarbituric acid test 

  26. Basic Clin. Pharmacol. Toxicol. Muriel 96 375 2005 10.1111/j.1742-7843.2005.pto_06.x Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid 

  27. Arch Pharm. Res. (Seoul) Parajuli 38 549 2015 10.1007/s12272-014-0425-2 Anti-fibrotic effect of PF2401-SF, a standardized fraction of Salvia miltiorrhiza, in thioacetamide-induced experimental rats liver fibrosis 

  28. Int. J. Occup. Med. Environ. Health Parke 9 331 1996 Chemical toxicity and reactive oxygen species 

  29. Metabolism Polyzos 92 82 2019 10.1016/j.metabol.2018.11.014 Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics 

  30. Hepatology Racanelli 43 S54 2006 10.1002/hep.21060 The liver as an immunological organ 

  31. J. Physiol. Pharmacol. Ramadori 59 Suppl. 1 107 2008 Physiology and pathophysiology of liver inflammation, damage and repair 

  32. Mol. Biol. Rep. Shi 39 9715 2012 10.1007/s11033-012-1836-0 Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis 

  33. J. Ethnopharmacol. Shin 153 142 2014 10.1016/j.jep.2014.01.039 Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice 

  34. J. Ethnopharmacol. Wang 140 179 2012 10.1016/j.jep.2012.01.007 Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model 

  35. J. Ethnopharmacol. Wang 135 344 2011 10.1016/j.jep.2011.03.026 An herbal fruit, Amomum xanthoides, ameliorates thioacetamide-induced hepatic fibrosis in rat via antioxidative system 

  36. Pharm. Biol. Wang 51 7 930 2013 10.3109/13880209.2013.770040 Hepatoprotective effect of Amomum xanthoides against dimethylnitrosamine-induced sub-chronic liver injury in a rat model 

  37. WHO 2016 Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015 

  38. J. Pharmacol. Sci. Yoneda 115 259 2011 10.1254/jphs.11R01FM Novel findings for the development of drug therapy for various liver diseases: preface 

  39. Hepatology Younossi 64 73 2016 10.1002/hep.28431 Global epidemiology of Nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes 

  40. J. Ethnopharmacol. Zhang 148 671 2013 10.1016/j.jep.2013.05.028 Multitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza 

  41. Front. Pharmacol. Zhou 7 201 2016 10.3389/fphar.2016.00201 Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research 

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로